These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31694793)

  • 1. Subcutaneous teicoplanin in staphylococcal bone and joint infections.
    Destrem AL; Valour F; Ronde-Ousteau C; Gaudias J; Rogeaux O; Ferry T; Forestier E
    Med Mal Infect; 2020 Feb; 50(1):83-86. PubMed ID: 31694793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections.
    El Samad Y; Lanoix JP; Bennis Y; Diouf M; Saroufim C; Brunschweiler B; Rousseau F; Joseph C; Hamdad F; Ait Amer Meziane M; Routier S; Schmit JL
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6365-8. PubMed ID: 27458228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
    Greenberg RN
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adequate use of teicoplanin in bone and joint infections].
    Senneville E; Legout L; Corroyer B; Yazdanpanah Y; Mouton Y
    Med Mal Infect; 2004 Jun; 34 Suppl 1():S99-102. PubMed ID: 15676260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of osteoarticular infections with clindamycin in adults].
    El Samad Y; Havet E; Bentayeb H; Olory B; Canarelli B; Lardanchet JF; Douadi Y; Rousseau F; Lescure FX; Mertl P; Eb F; Schmit JL
    Med Mal Infect; 2008 Sep; 38(9):465-70. PubMed ID: 18718729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of initial loading procedure for teicoplanin in critically ill patients with severe infections.
    Matsumoto K; Kanazawa N; Watanabe E; Yokoyama Y; Fukamizu T; Shimodozono Y; Maeda C; Yasuda T; Kakihana Y; Ikawa K; Morikawa N; Takeda Y
    Biol Pharm Bull; 2013; 36(6):1024-6. PubMed ID: 23727923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level.
    Sato M; Chida K; Suda T; Muramatsu H; Suzuki Y; Hashimoto H; Gemma H; Nakamura H
    J Infect Chemother; 2006 Aug; 12(4):185-9. PubMed ID: 16944256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusidic acid in staphylococcal bone and joint infection.
    Coombs RR
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():53-60. PubMed ID: 2179204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of cefprozil as part of a parenteral-oral antibiotic regimen for the treatment of suppurative skeletal infections in children.
    Trujillo M; Ehrett S; Hoyt-Sehnert MJ; Shelton S; McCracken GH
    Clin Infect Dis; 1996 Oct; 23(4):843. PubMed ID: 8909865
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneously administered antibiotics.
    Colin E; Baldolli A; Verdon R; Saint-Lorant G
    Med Mal Infect; 2020 May; 50(3):231-242. PubMed ID: 31300245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics.
    Niwa T; Imanishi Y; Ohmori T; Matsuura K; Murakami N; Itoh Y
    Int J Antimicrob Agents; 2010 May; 35(5):507-10. PubMed ID: 20185275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.
    Matsumoto K; Kanazawa N; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    J Infect Chemother; 2010 Jun; 16(3):193-9. PubMed ID: 20195882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Teicoplanin in the treatment of bone and joint infections due to methicillin resistant staphylococci. Experience in adult patients].
    Pensotti C; Nacinovich F; Vidiella G; Carbone E; Marin M; Di Stéfano C; Stamboulian D
    Medicina (B Aires); 2002; 62 Suppl 2():40-7. PubMed ID: 12481488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of teicoplanin and ceftriaxone in combination against pathogens involved in paediatric bone and joint infections.
    Lhopital S; Bonacorsi S; Doit C; Sandin A; Bingen E
    J Antimicrob Chemother; 1996 Oct; 38(4):713-8. PubMed ID: 8937966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bolus or infusion teicoplanin for intravascular catheter associated infections in immunocompromised patients?
    Ley BE; Jalil N; McIntosh J; Smart A; Wilson M; Foot AB; Millar MR
    J Antimicrob Chemother; 1996 Dec; 38(6):1091-5. PubMed ID: 9023659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish experience with teicoplanin.
    Fernández-Guerrero M; Gobernado M; Ariza J; Williams A
    Scand J Infect Dis Suppl; 1990; 72():38-44. PubMed ID: 2151066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified chart for determining the initial loading dose of teicoplanin in critically ill patients.
    Yoshida S; Suzuki A; Ohmori T; Niwa T; Okada H; Suzuki K; Kobayashi R; Doi T; Kitaichi K; Matsuura K; Murakami N; Ogura S; Itoh Y
    Pharmazie; 2017 Jan; 72(1):53-57. PubMed ID: 29441898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin levels in bone and joint infections: are standard doses subtherapeutic?
    Matthews PC; Taylor A; Byren I; Atkins BL
    J Infect; 2007 Nov; 55(5):408-13. PubMed ID: 17825421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.